These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3326026)
1. Pharmacogenetics and its clinical implications: N-acetylation polymorphism. Horai Y; Ishizaki T Ration Drug Ther; 1987 Oct; 21(10):1-7. PubMed ID: 3326026 [No Abstract] [Full Text] [Related]
2. Acetylator status, drug metabolism and disease. Pande JN; Pande A; Singh SP Natl Med J India; 2003; 16(1):24-6. PubMed ID: 12715953 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic polymorphism of drug metabolism. Paxton JW N Z Med J; 1984 Aug; 97(762):567-9. PubMed ID: 6591031 [No Abstract] [Full Text] [Related]
4. Relationship of acetylator status to isoniazid toxicity, lupus erythematosus, and bladder cancer. Weber WW; Hein DW; Litwin A; Lower GM Fed Proc; 1983 Nov; 42(14):3086-97. PubMed ID: 6628700 [No Abstract] [Full Text] [Related]
5. Ethnic differences in reactions to drugs and xenobiotics. Acetylation. Evans DA Prog Clin Biol Res; 1986; 214():209-42. PubMed ID: 3523508 [No Abstract] [Full Text] [Related]
6. The biochemical indices of genetic susceptibility to cancer. Acetylation phenotype and bladder cancer. Hanke J; Krajewska B Pol J Occup Med; 1988; 1(4):306-11. PubMed ID: 2979565 [No Abstract] [Full Text] [Related]
8. Genetic polymorphism and cancer susceptibility: evidence concerning acetyltransferases and cancer of the urinary bladder. Hein DW Bioessays; 1988 Dec; 9(6):200-4. PubMed ID: 3072000 [No Abstract] [Full Text] [Related]
9. Drug acetylator phenotypes in newborn infants. Szórády I; Sánta A; Veress I Biol Res Pregnancy Perinatol; 1987; 8(1 1ST Half):23-5. PubMed ID: 3580445 [TBL] [Abstract][Full Text] [Related]
10. Inherited defects of hepatic drug metabolism. Küpfer A; Preisig R Semin Liver Dis; 1983 Nov; 3(4):341-54. PubMed ID: 6417793 [No Abstract] [Full Text] [Related]
11. Drug acetylation phenotype in systemic lupus erythematosus. Fine RM Int J Dermatol; 1979 Dec; 18(10):811. PubMed ID: 528101 [No Abstract] [Full Text] [Related]
12. [Acetylation phenotype in patients with systemic lupus erythematosus]. Iakushkevich TN; Tareeva IE; Tuganbekova SK; Kovaleva VL; Evstaf'eva OL Ter Arkh; 1985; 57(8):82-4. PubMed ID: 3865448 [No Abstract] [Full Text] [Related]
13. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels. Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698 [TBL] [Abstract][Full Text] [Related]
14. [Polymorphic acetylation in women with genital neoplasms]. Tomaszkiewicz T; Markowska J; Simm S; Herwichowska K Pol Tyg Lek; 1979 Sep; 34(39):1521-3. PubMed ID: 503961 [No Abstract] [Full Text] [Related]
15. Antinuclear antibodies related to acetylator phenotype in mice. Tannen RH; Weber WW J Pharmacol Exp Ther; 1980 Jun; 213(3):485-90. PubMed ID: 6970809 [TBL] [Abstract][Full Text] [Related]
16. Ethnic differences in reactions to drugs and xenobiotics. Therapy. Evans DA Prog Clin Biol Res; 1986; 214():491-526. PubMed ID: 3523517 [No Abstract] [Full Text] [Related]
17. Use of pharmacogenetics, enzymatic phenotyping, and metabolite monitoring to guide treatment with azathioprine in patients with systemic lupus erythematosus. Askanase AD; Wallace DJ; Weisman MH; Tseng CE; Bernstein L; Belmont HM; Seidman E; Ishimori M; Izmirly PM; Buyon JP J Rheumatol; 2009 Jan; 36(1):89-95. PubMed ID: 19040311 [TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis of systemic lupus erythematosus: effect of aromatic amines]. Merk H Z Hautkr; 1984 Jun; 59(11):709-10. PubMed ID: 6485446 [No Abstract] [Full Text] [Related]
19. Genes encoding drug-metabolizing enzymes: possible role in human disease. Nebert DW Basic Life Sci; 1988; 43():45-64. PubMed ID: 2896496 [No Abstract] [Full Text] [Related]